• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,649.84 382.50
( 0.52%)
Global Indices
Nasdaq
51,095.09 41.63
(0.08%)
Dow Jones
7,620.62 19.56
(0.26%)
Hang Seng
66,649.95 -284.38
(-0.42%)
Nikkei 225
10,376.42 37.47
(0.36%)
Forex
USD-INR
94.75 -1.18
(-1.23%)
EUR-INR
110.47 -1.07
(-0.96%)
GBP-INR
127.45 -1.26
(-0.98%)
JPY-INR
0.59 -0.01
(-1.17%)

EQUITY - MARKET SCREENER

Bharat Immunological & Biological Corporation Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524663
INE994B01014
-7.5352246
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
75.78
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

emco ltd
Makers Laboratories reports consolidated net profit of Rs 1.09 crore in the March 2026 quarter
May 26,2026
Net profit of Makers Laboratories reported to Rs 1.09 crore in the quarter ended March 2026 as against net loss of Rs 0.05 crore during the previous quarter ended March 2025. Sales rose 5.46% to Rs 35.75 crore in the quarter ended March 2026 as against Rs 33.90 crore during the previous quarter ended March 2025.

For the full year,net profit declined 68.62% to Rs 2.35 crore in the year ended March 2026 as against Rs 7.49 crore during the previous year ended March 2025. Sales rose 16.43% to Rs 140.59 crore in the year ended March 2026 as against Rs 120.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales35.7533.90 5 140.59120.75 16
OPM %14.749.12 -10.486.94 -
PBDT5.873.03 94 15.688.89 76
PBT4.732.13 122 11.154.10 172
NP1.09-0.05 LP 2.357.49 -69